Regulations that limit fundamental human rights should be accompanied by a transparent risk and benefit analysis.
Articles on SARS-CoV-2
Displaying 101 - 120 of 605 articles
Despite the halt to the federal mask mandate for mass transit, people may still choose to protect themselves. For those who do, the type of mask and how well it fits matter.
The Valneva vaccine is the sixth COVID vaccine to be approved in the UK.
At this point it’s pragmatic to integrate COVID-19 management into routine health practices.
Earlier detection and treatment of COVID-19 by health care providers in pharmacies could help prevent surges in infection rates and severe illness.
Classical antibiotics that directly kill pathogens are prone to elicit drug-resistance. Targeting host enzymes required for pathogen survival offers can limit the emergence of resistance.
Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.
Evusheld is an antibody drug from AstraZeneca intended to help prevent COVID-19 infection for immunocompromised and other vulnerable patients.
The latest addition to the omicron lineage has been making waves in Europe. Whether it will do the same in the U.S. depends on rates of vaccination and prior infection.
It feels like everyone around you has or is recovering from COVID. Maybe you’re fatigued and wondering if it’s an after-effect? Antibody tests could confirm it one way or another.
A robust body of research finds that getting vaccinated against COVID-19 during pregnancy is safe and effective – and the best way to protect both mother and child from the risks of COVID-19.
The COVID-19 pandemic has brought immunology terms that are typically relegated to textbooks into our everyday vernacular. These stories helped us make sense of the ever-evolving science.
COVID cases are predicted to rise as we face another variant. So a 4th shot to top up our immunity is looking more likely as we head into winter.
A highlight of this pandemic is how quickly effective vaccines were developed and rolled out.
It’s a huge cause for concern that, two years into the pandemic, the disparities and unequal power structures in global health are still intact.
3D printers got a lot of attention when DIYers leapt to action to address equipment shortages early in the pandemic, but some everyday items found in hardware stores played a big role, too.
Before COVID-19, clean water, antibiotics and vaccines had made us complacent about infectious disease. Infection control can no longer be taken for granted. We must be prepared for future pandemics.
The fear that SARS-CoV-2 will evolve in animals and then spread back to us in a more virulent form is unfounded.
In 2020 TB case detection fell by almost 20% and mortality rose for the first time in a decade. These setbacks are directly attributable to the COVID-19 pandemic.
The delay in finding definitive answers to how novel infectious diseases come about is not unusual. Look at what happened to our search for Ebola virus.
Top contributors
-
Professor of Medicine, University of Virginia
-
Associate Professor, Epidemiology, Deakin University
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor and Research Leader in Virology and Infectious Disease, Griffith University
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Instructor of Human Immunology, Emory University
-
Professor Emerita, Nursing, School of Nursing and Midwifery, Griffith University
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Scientific Officer in Biomedical Sciences, University of Leeds
-
Postdoctoral Fellow in Virology and Immunology, University of Colorado Boulder
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
-
Lecturer in Virology, Queen's University Belfast